Testing effectiveness (Phase 2)Study completedNCT03733990
What this trial is testing
Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
Who this might be right for
Cancer
Faron Pharmaceuticals Ltd 216
Showing 20 of 71 results